re: company update on the following then Bringitere , they will...

re: company update on the following then Bringitere , they will also be acutely aware of how 002 can fire up an immune attack against the cancer site . That is what all these vaccines are trying to do with varying success . The cancer vaccines so far have come up short as a complete treatment and there are very few drugs they can combine with that do not have an adverse effect on the immune system , and therefore the action of the vaccine . That is why I do not doubt for a second Steve Carters report of approaches by most of the majors .
I know the delays have been frustrating . The problems at the hospital have been sorted I believe . A total of 4 years from concept to phase 2 is not so far out . If everything had gone 100% they could have been in phase2 now , but that is not so far away . As an example , check out how long Progen took from concept to phase2 .During those delays , Solbec have developed a second application , a psoraisis drug that starts clinical shortly as a cream . As it is a topical application these trials should be fast . Market is worth billions .
I think it is a mistake to focus on the problems they have had to overcome when there are so many positives .
The options are being sold down because in september they change from 12c to 20c options . When the phase 1 results follow that should still be cheap . IMHO